"Designing Growth Strategies is in our DNA"

Pharmacovigilance (PV) Market Size, Share & COVID-19 Impact Analysis, By Type (Service and Software), By Deployment (In-house and Outsource), By End-User (Hospitals, Pharmaceutical Companies, and Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI102746

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview of Trends in Pharmacovigilance Industry
    2. Snapshot of Rate of Adverse Drug Reactions – By Key Region/Countries
    3. Regulatory Scenario in the Pharmacovigilance Industry
    4. Overview of Government Initiatives in Safe Medicine Use
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Type
      2. Canada
        1. By Type
  7. Europe Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Type
      2. Germany
        1. By Type
      3. France
        1. By Type
      4. Spain
        1. By Type
      5. Italy
        1. By Type
      6. Scandinavia
        1. By Type
      7. Rest of Europe
        1. By Type
  8. Asia Pacific Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Type
      2. China
        1. By Type
      3. India
        1. By Type
      4. Australia
        1. By Type
      5. Southeast Asia
        1. By Type
      6. Rest of Asia Pacific
        1. By Type
  9. Latin America Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Type
      2. Mexico
        1. By Type
      3. Rest of Latin America
        1. By Type
  10. Middle East & Africa Pharmacovigilance (PV) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Service
      2. Software
    3. Market Analysis, Insights and Forecast – By Deployment
      1. In-house
      2. Outsource
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Pharmaceutical Companies
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Type
      2. South Africa
        1. By Type
      3. Rest of Middle East & Africa
        1. By Type
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Product Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. IQVIA (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Covance Inc. (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Parexel International Corporation (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Accenture Plc (Ireland)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Cognizant (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Bioclinica (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Pharmaceutical Product Development, LLC (U. S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. ICON Plc (Ireland)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Quanticate (U.S)
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Pharmacovigilance (PV) Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 2:  Global Pharmacovigilance (PV) Market Value Share (%), by Type, 2020 & 2028

Figure 3:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Service, 2017-2028

Figure 4:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Software 2017-2028

Figure 5:  Global Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020 & 2028

Figure 6:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by In-house, 2017-2028

Figure 7:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Outsource, 2017-2028

Figure 8:  Global Pharmacovigilance (PV) Market Value Share (%), by End User, 2020 & 2028

Figure 9:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Hospitals, 2017-2028

Figure 10:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Pharmaceutical Companies, 2017-2028

Figure 11:  Global Pharmacovigilance (PV) Market Forecast (USD billion), by Others, 2017-2028

Figure 12:  Global Pharmacovigilance (PV) Market Value (USD billion), by Region, 2020 & 2028

Figure 13:  North America Pharmacovigilance (PV) Market Value (USD billion), by Type, 2020 & 2028

Figure 14:  North America Pharmacovigilance (PV) Market Value Share (%), by Type, 2020

Figure 15:  North America Pharmacovigilance (PV) Market Value (USD billion), by Deployment, 2020 & 2028

Figure 16:  North America Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020

Figure 17:  North America Pharmacovigilance (PV) Market Value (USD billion), by End User, 2020 & 2028

Figure 18:  North America Pharmacovigilance (PV) Market Value Share (%), by End User, 2020

Figure 19:  North America Pharmacovigilance (PV) Market Value (USD billion), By Country, 2020 & 2028

Figure 20:  North America Pharmacovigilance (PV) Market Value Share (%), By Country, 2020

Figure 21:  Europe Pharmacovigilance (PV) Market Value (USD billion), by Type, 2020 & 2028

Figure 22:  Europe Pharmacovigilance (PV) Market Value Share (%), by Type, 2020

Figure 23:  Europe Pharmacovigilance (PV) Market Value (USD billion), by Deployment, 2020 & 2028

Figure 24:  Europe Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020

Figure 25:  Europe Pharmacovigilance (PV) Market Value (USD billion), by End User, 2020 & 2028

Figure 26:  Europe Pharmacovigilance (PV) Market Value Share (%), by End User, 2020

Figure 27:  Europe Pharmacovigilance (PV) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 28:  Europe Pharmacovigilance (PV) Market Value Share (%), By Country/ Sub-region, 2020

Figure 29:  Asia Pacific Pharmacovigilance (PV) Market Value (USD billion), by Type, 2020 & 2028

Figure 30:  Asia Pacific Pharmacovigilance (PV) Market Value Share (%), by Type, 2020

Figure 31:  Asia Pacific Pharmacovigilance (PV) Market Value (USD billion), by Deployment, 2020 & 2028

Figure 32:  Asia Pacific Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020

Figure 33:  Asia Pacific Pharmacovigilance (PV) Market Value (USD billion), by End User, 2020 & 2028

Figure 34:  Asia Pacific Pharmacovigilance (PV) Market Value Share (%), by End User, 2020

Figure 35:  Asia Pacific Pharmacovigilance (PV) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 36:  Asia Pacific Pharmacovigilance (PV) Market Value Share (%), By Country/ Sub-region, 2020

Figure 37:  Latin America Pharmacovigilance (PV) Market Value (USD billion), by Type, 2020 & 2028

Figure 38:  Latin America Pharmacovigilance (PV) Market Value Share (%), by Type, 2020

Figure 39:  Latin America Pharmacovigilance (PV) Market Value (USD billion), by Deployment, 2020 & 2028

Figure 40:  Latin America Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020

Figure 41:  Latin America Pharmacovigilance (PV) Market Value (USD billion), by End User, 2020 & 2028

Figure 42:  Latin America Pharmacovigilance (PV) Market Value Share (%), by End User, 2020

Figure 43:  Latin America Pharmacovigilance (PV) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 44:  Latin America Pharmacovigilance (PV) Market Value Share (%), By Country/ Sub-region, 2020

Figure 45:  Middle East & Africa Pharmacovigilance (PV) Market Value (USD billion), by Type, 2020 & 2028

Figure 46:  Middle East & Africa Pharmacovigilance (PV) Market Value Share (%), by Type, 2020

Figure 47:  Middle East & Africa Pharmacovigilance (PV) Market Value (USD billion), by Deployment, 2020 & 2028

Figure 48:  Middle East & Africa Pharmacovigilance (PV) Market Value Share (%), by Deployment, 2020

Figure 49:  Middle East & Africa Pharmacovigilance (PV) Market Value (USD billion), by End User, 2020 & 2028

Figure 50:  Middle East & Africa Pharmacovigilance (PV) Market Value Share (%), by End User, 2020

Figure 51:  Middle East & Africa Pharmacovigilance (PV) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 52:  Middle East & Africa Pharmacovigilance (PV) Market Value Share (%), By Country/ Sub-region, 2020

Figure 53:  Global Pharmacovigilance (PV) Market Share (%), By Company, 2020

Table 1:  Global Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017–2028

Table 2:  Global Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017–2028

Table 3:  Global Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017–2028

Table 4:  Global Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 5:  North America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 6:  North America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017-2028

Table 7:  North America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 8:  North America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, By Country, 2017-2028

Table 9:  U.S. Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 10:  Canada Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 11:  Europe Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 12:  Europe Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017-2028

Table 13:  Europe Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 14:  Europe Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 15:  U.K. Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 16:  Germany Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 17:  France Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 18:  Spain Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 19:  Italy Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 20:  Scandinavia Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 21:  Rest of Europe Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 22:  Asia Pacific Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 23:  Asia Pacific Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017-2028

Table 24:  Asia Pacific Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 25:  Asia Pacific Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 26:  Japan Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 27:  China Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 28:  India Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 29:  Australia Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 30:  Southeast Asia Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 31:  Rest of Asia Pacific Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 32:  Latin America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 33:  Latin America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017-2028

Table 34:  Latin America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 35:  Latin America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 36:  Brazil Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 37:  Mexico Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 38:  Rest of Latin America Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 39:  Middle East & Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 40:  Middle East & Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Deployment, 2017-2028

Table 41:  Middle East & Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 42:  Middle East & Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 43:  South Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 44:  GCC Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 45:  Rest of Middle East & Africa Pharmacovigilance (PV) Market Revenue (USD billion) Forecast, by Type, 2017-2028

  • Dec, 2021
  • 2020
  • 2017-2019
  • 113

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X